Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-05

Clinical Trial Update: Effectiveness and Safety of Salba on Weight Loss in Overweight Individuals With Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the effectiveness and safety of Salba for weight loss in overweight adults with type 2 diabetes; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Salba

Snippet

Sponsor: Unity Health Toronto | Conditions: Diabetes Mellitus, Overweight | Phase 2 | Status: COMPLETED